Levity’s current homepage says its subscription service has closed and moved to its sister brand, ZipHealth. That notice changes how the page should be read: older prices and service descriptions still visible below it are not a reliable offer for a new Levity subscription.
We retain this review because existing customers and people finding older comparisons may still search for Levity. It is a transition file, not a recommendation to enroll through an outdated subscription description.
What the service actually offers
The prominent notice directs readers to ZipHealth for the next service pathway. It does not, on its own, explain every existing customer’s clinical, billing or records arrangement. An old treatment history should be reviewed by the appropriate clinician; a move between websites is not a self-directed prescription transfer.
Read the bill in full
If you previously paid Levity, identify the last charge, remaining paid period and any renewal authorization. Ask the account team what has ended, what may transfer and whether a new financial agreement is required. Do not treat historical monthly prices lower on the page as a current quote from ZipHealth. Obtain the new service’s actual terms separately.
After the first order
Continuity requires more than an account login. Ask who holds your treatment record, how to obtain it and which clinical team can advise about the next scheduled review. If you have medication questions while the transition is unresolved, contact the treating clinician or dispensing pharmacist rather than waiting for a general website update.
Keep a useful paper trail
Keep the closure notice with your original plan documents and any transition email. Ask a focused question about the status of the account or record you need. Preserve responses so the next provider can understand the administrative timeline without making you repeat a complete history in multiple unsecured channels.
- Has my previous subscription ended, and are any future charges authorized?
- How can I obtain my prescription and clinical records securely?
- Do I need a new assessment and agreement with the successor service?
Our reading of the trade-off
Levity should not be placed in an active enrollment ranking based on its old offer. The useful action is to resolve existing records and payment questions and then assess any successor provider on its current terms. Its transition illustrates why a review library needs dated source checks rather than permanent assumptions about a brand.
What this review can establish
This is a desk review of published information, not a treatment trial, mystery-shopper order or verified complaint history. A provider’s website can establish what it advertises; it cannot show how reliably an individual request will be handled. We have not measured this service’s response time, refund performance or patient outcomes.
The prescription itself needs a separate clinical assessment. FDA-approved products and compounded preparations have different evidence and regulatory status. Compounded drugs are not FDA-approved, and a branded drug’s trial results cannot be assigned to a provider’s compound. Bring medication and safety questions to the prescribing clinician and dispensing pharmacist.
Turn the question into a useful message.
Choose a billing, delivery, account or treatment topic. Our support note builder gives you a short checklist and a draft to take to the right team.
Build your noteSources for this file
Provider sources describe advertised services; they do not establish delivery performance or patient outcomes. Medical sources support the educational context. Review date: 2026-10-05.